Selective toll-like receptor 7 (TLR7) agonist. Immune response modifier. Antiviral and antitumor compound. Induces the activation of NF-kappaB in HEK 293 cells expressing TLR7 at 0. 1µg/ml. 10 times more active than Imiquimod. At high concentrations (3µg/ml) slightly activates TLR8. Shows adjuvant activity to increase the effectiveness of vaccines.
Solubility & Handling
Storage instructions
+4°C
Important
This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use.
![Gardiquimod [1020412-43-4] Chemical Structure](https://cdn.hellobio.com/media/catalog/product//h/b/hb3915.png "Gardiquimod [1020412-43-4]")
Understanding purity and quality - a guide for life scientists